Sign In
Sign Out
My Account
Subscribe
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
Special reports
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Infographics: Dynamic digital data analysis
Trump administration impacts
Biopharma M&A scorecard
BioWorld 2024 review
BioWorld MedTech 2024 review
BioWorld Science 2024 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Israel
Rise of obesity
Radiopharmaceuticals
Biosimilars
Aging
IVDs on the rise
Coronavirus
Artificial intelligence
BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Infographics: Dynamic digital data analysis
Trump administration impacts
Biopharma M&A scorecard
BioWorld 2024 review
BioWorld MedTech 2024 review
BioWorld Science 2024 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Israel
Rise of obesity
Radiopharmaceuticals
Biosimilars
Aging
IVDs on the rise
Coronavirus
Artificial intelligence
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
Home
»
Newsletters
» BioWorld Science
BioWorld Science
April 13, 2000
View Archived Issues
Coulter's CPI-0004Na prodrug shows promising preclinical profile
Read More
Collgard updates development status of halofuginone
Read More
Periodontix tests sustained silver delivery for periodontitis
Read More
Cambridge Discovery Chemistry moves forward in deal with AstraZeneca
Read More
Butyrylcholinesterase inhibition heralded as potential new treatment strategy for AD
Read More
Interferon alfa-2b offers protection from eye involvement in Behcet's disease
Read More
Phase III results in for pleconaril: ViroPharma reaffirms commitment to novel antiviral drug
Read More
BioTransplant initiates phase I/II trial of AlloMune
Read More
Approval of Gliadel Wafer in Spain triggers milestone payment to Guilford
Read More
U.S. researchers design PDGF-binding antitumor and antiangiogenic compound
Read More
Celsion completes expanded phase I trial for BPH therapy
Read More
TLC-144, a new ceramide derivative, induces apoptosis in tumor cells by activating specific caspase
Read More
NIDA recommends Nabi-NicVAX funding for treatment and prevention of nicotine dependence
Read More
Plant extract in active development at Ozelle for cancer profiled at AACR meeting
Read More
Tamiflu launched in Latin America
Read More
Iron chelator undergoing evaluation as antitumor agent by U.S. researchers
Read More
Novel angiogenesis inhibitor discussed by Eisai at recent cancer meeting
Read More
Loss of hepatitis B antigen increases with increasing duration of lamivudine therapy
Read More
New sulfonylureidopyrazoles for endothelin-related disorders
Read More
Potent antitumor agents produced by microorganism discovered by Snow Brand
Read More
Organoselenium compounds as antioxidants, cytoprotective agents presented by Oxis
Read More
BE-70016: new antitumor compound produced by strain of Actinoplanes
Read More
Chimeric GRF analogues with enhanced potency designed by Theratechnologies
Read More
Nippon Soda discloses newest agents for lipid disorders
Read More
Antiasthmatics in early development at Tanabe Seiyaku
Read More
WHI study continues despite early increase in cardiac events with HRT
Read More
FDA approves Visudyne therapy for treatment of AMD
Read More
BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Infographics: Dynamic digital data analysis
Trump administration impacts
Biopharma M&A scorecard
BioWorld 2024 review
BioWorld MedTech 2024 review
BioWorld Science 2024 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Israel
Rise of obesity
Radiopharmaceuticals
Biosimilars
Aging
IVDs on the rise
Coronavirus
Artificial intelligence
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe